4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-009124
Chief Medical Officer sold 161,139 shares at an average $16.88 ($2,719,493)
- Chief Medical Officer acquired 148,302 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sheridan William P Chief Medical Officer | 2022-03-10 | Option exercise | +148,302 | $3.22 | $477,532 | 199,093 | D |
| Sheridan William P Chief Medical Officer | 2022-03-10 | Sale | −159,739 | $16.87 | $2,694,797 | 39,354 | D |
| Sheridan William P Chief Medical Officer | 2022-03-10 | Sale | −1,400 | $17.64 | $24,696 | 37,954 | D |
| Derivatives | |||||||
| Sheridan William P Chief Medical Officer | 2022-03-10 | Option exercise · Emp. Stock Option (Right to Buy) | −148,302 | 0 | D | ||
| Open-market sales · 161,139 sh · avg $16.88 · $2,719,493 | |||||||
Loading xslF345X03/form4.xml…